# Population-agnostic real-time molecular mismatch estimation using rSSO-defined HLA allele strings: minimal impact of allelic discordance with NGS

**Authors:** Raja Rajalingam, Pawan Kumar Raghav, Neelam Sharma, Gilberto Da Gente, Denice Kong

PMC · DOI: 10.3389/fimmu.2026.1781594 · Frontiers in Immunology · 2026-03-11

## TL;DR

This study shows that a specific HLA typing method can reliably estimate molecular mismatches in transplants, even when high-resolution data is not available.

## Contribution

The study introduces a population-agnostic method using rSSO MAC strings as a practical surrogate for high-resolution HLA typing in mismatch assessment.

## Key findings

- The first allele in rSSO MAC strings showed over 94% concordance with NGS alleles for most HLA loci.
- Most discordant alleles did not significantly increase eplet mismatches, with over 77% having two or fewer mismatches.
- The method works reliably across different racial and ethnic groups, with minimal clinically meaningful mismatch increases.

## Abstract

Molecular HLA mismatch at the epitope level is strongly associated with donor-specific antibody formation, antibody-mediated rejection, and graft failure after transplantation. Accurate molecular mismatch assessment requires high-resolution HLA typing; however, in clinical practice—particularly in deceased donor transplantation—typing is often performed at low or intermediate resolution. Haplotype-based imputation methods have been developed to infer high-resolution alleles but show variable accuracy, particularly in underrepresented populations. We evaluated whether the first allele listed in the reverse sequence-specific oligonucleotide (rSSO)–derived National Marrow Donor Program (NMDP) multiple allele code (MAC) string can serve as a practical surrogate for high-resolution typing in molecular mismatch assessment.

We analyzed 4,738 individuals who underwent dual HLA typing by rSSO and next-generation sequencing (NGS) across 11 classical HLA loci. Concordance between the first allele of the rSSO MAC string and the corresponding two-field NGS allele was assessed. For discordant allele pairs, molecular disparity was quantified by calculating eplet mismatches using the HLA Eplet Mismatch Calculator.

Allele-level concordance exceeded 94% for 9 of 11 loci, including HLA-A (97.9%), -B (98.5%), -C (95.2%), -DRB1 (96.8%), -DRB3 (94.5%), -DRB5 (99.6%), -DQB1 (98.3%), -DPB1 (96.8%), and -DPA1 (98.7%). Lower concordance was observed for HLA-DQA1 (86.7%) and -DRB4 (72.0%). Most discordant NGS alleles, except for the DPB1 locus, were present in the rSSO MAC string. Among discordant allele pairs, 30.4% had zero eplet mismatches and 77.6% had two or fewer mismatched eplets. Allele pairs with more than two mismatched eplets accounted for less than 0.3% of all comparisons across loci. No significant differences in concordance were observed across racial or ethnic groups.

The first allele listed in the rSSO-derived MAC string provides a reliable, population-agnostic surrogate for high-resolution HLA typing in molecular mismatch assessment. Although allele-level discordance occurs, it rarely results in clinically meaningful increases in eplet mismatch burden. This laboratory-based approach enables real-time molecular mismatch estimation in time-sensitive settings and facilitates retrospective analysis of cohorts lacking sequencing-based HLA data, supporting broader integration of molecular mismatch into precision transplantation practice.

## Linked entities

- **Genes:** HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105], HLA-B (major histocompatibility complex, class I, B) [NCBI Gene 3106], HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107], HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123], HLA-DRB3 (major histocompatibility complex, class II, DR beta 3) [NCBI Gene 3125], HLA-DRB5 (major histocompatibility complex, class II, DR beta 5) [NCBI Gene 3127], HLA-DQB1 (major histocompatibility complex, class II, DQ beta 1) [NCBI Gene 3119], HLA-DPB1 (major histocompatibility complex, class II, DP beta 1) [NCBI Gene 3115], HLA-DPA1 (major histocompatibility complex, class II, DP alpha 1) [NCBI Gene 3113], HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1) [NCBI Gene 3117], HLA-DRB4 (major histocompatibility complex, class II, DR beta 4) [NCBI Gene 3126]

## Full-text entities

- **Genes:** HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1) [NCBI Gene 3117] {aka CELIAC1, DQ-A1, DQA1, HLA-DQA, HLA-DQA1*}, HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123] {aka DRB1, HLA-DR1B, HLA-DRB, SS1}, HLA-DQB1 (major histocompatibility complex, class II, DQ beta 1) [NCBI Gene 3119] {aka CELIAC1, HLA-DQB, IDDM1}, HLA-DPB1 (major histocompatibility complex, class II, DP beta 1) [NCBI Gene 3115] {aka DPB1, HLA-DP, HLA-DP1B, HLA-DPB}, HLA-DRB4 (major histocompatibility complex, class II, DR beta 4) [NCBI Gene 3126] {aka DR4, DRB4, HLA-DR4B, HLA-DRB, HLA-DRB4*}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13013013/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13013013/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC13013013/full.md

---
Source: https://tomesphere.com/paper/PMC13013013